Package insert. Fungizone (amphotericin B). Princeton, NJ: Apothecon, a Bristol-Myers Squibb Co., revised September 1993.
2.
KintzelPESmithGH. Practical guidelines for preparing and administering amphotericin B. Am J Hosp Pharm1992;49:1156–64.
3.
HoeprichPD. Clinical use of amphotericin B and derivatives: Lore, mystique, and fact. Clin Infect Dis1992;14(suppl 1): S114–9.
4.
MurrayHW. Allergic reactions to amphotericin B (letter). N Engl J Med1974;290:693.
5.
LorberBCutlerCBarryWE. Allergic rash due to amphotericin B (letter). Ann Intern Med1976;84:54.
6.
KempSFLockeyRF. Amphotericin B: Emergency challenge in a neutropenic, asthmatic patient with fungal sepsis. J Allergy Clin Immunol1995;96:425–7.
7.
SullivanGWCarperHTMandellGL. Pentoxifylline modulates activation of human neutrophils by amphotericin B in vitro. Antimicrob Agents Chemother1992;36:408–16.
8.
ClearyJDChapmanSWNolanRL. Pharmacologic modulation of interleukin-1 expression by amphotericin B-stimulated human mononuclear cells. Antimicrob Agents Chemother1992;36:977–81.
9.
BerlinerSWeinbergerMBen-BassatMLavieGWeinbergerAGillerSAmphotericin B causes aggregation of neutrophils and enhances pulmonary leukostasis. Am Rev Respir Dis1985;132:602–5.
10.
GigliottiFShenepJLLottLThorntonD. Induction of prostaglandin synthesis as the mechanism responsible for the chills and fever produced by infusing amphotericin B. J Infect Dis1987;156:784–9.
11.
GraselaTHGoodwinSDWalawanderMKCramerRLFuhsDWMoriartyVP. Prospective surveillance of intravenous amphotericin B use patterns. Pharmacotherapy1990;10:341–8.
12.
ArningMDresenBAulCSchneiderW. Influence of infusion time on the acute toxicity of amphotericin B: Results of a randomized double-blind study. Recent Results Cancer Res1991;121:347–52.
13.
ClearyJDWeisdorfDFletcherCV. Effect of infusion rate on amphotericin B-associated febrile reactions. Drug Intell Clin Pharm1988;22:769–72.
14.
OldfieldECGarstPDHostettlerCWhiteMSamuelsonD. Randomized, double-blind trial of 1- versus 4-hour amphotericin B infusion durations. Antimicrob Agents Chemother1990;34:1402–6.
15.
NichollTANimmoC ReesorShepherdJDPhillipsPJewessonPJ. Amphotericin B infusion-related toxicity: Comparison of two- and four-hour infusions. Ann Pharmacother1995;29:1081–7.
16.
CruzJMPeacockJELoomerLHolderLWEvansGWPowellBLRapid intravenous infusion of amphotericin B: A pilot study. Am J Med1992;93:123–30.
17.
EllisMEAl-HokailAAClinkHMPadmosMAErnstPSpenceDGDouble-blind randomized study of the effect of infusion rates on toxicity of amphotericin B. Antimicrob Agents Chemother1992;36:172–9.
18.
GoodwinSDClearyJDWalawanderCATaylorJWGraselaTH. pretreatment regimens for adverse events related to infusion of amphotericin B. Clin Infect Dis1995;20:755–61.
